As biotech turns 20...

Henry I Miller
Author Information
  1. Henry I Miller: Hoover Institution, Stanford University, Stanford, California 94305-6010, USA. miller@hoover.stanford.edu

Abstract

Biotechnology applied to pharmaceuticals has made significant contributions to medicine during the past 20 years. Although important products will continue to emerge, benefiting patients and perhaps lowering medical costs, there are too many biopharmaceutical companies chasing too few products, which are themselves over-regulated and incredibly expensive to test and bring to market.

MeSH Term

Biotechnology
Drug Costs
Drug Industry
Humans

Word Cloud

Created with Highcharts 10.0.020productsBiotechnologyappliedpharmaceuticalsmadesignificantcontributionsmedicinepastyearsAlthoughimportantwillcontinueemergebenefitingpatientsperhapsloweringmedicalcostsmanybiopharmaceuticalcompanieschasingover-regulatedincrediblyexpensivetestbringmarketbiotechturns

Similar Articles

Cited By